Estrogen inhibits hepatocellular carcinoma progression dependent on HOXA11-AS/HOXA11
Estrogen and its related proteins have therapeutic effects in HCC and may be new potential therapeutic targets.
Authors
- J.Z. Wang (ORCID: https://orcid.org/0009-0005-4264-129X)
- Haiqing Ma (ORCID: https://orcid.org/0000-0002-5524-6097)
- Fengze Sun (ORCID: https://orcid.org/0000-0002-8816-360X)
- Jiayao Liu (ORCID: https://orcid.org/0009-0001-4551-0990)
- Yan Yan (ORCID: https://orcid.org/0000-0003-4993-3621)
- Pengcheng Liu (ORCID: https://orcid.org/0000-0002-4808-3066)
- Pei-Yu Lin (ORCID: https://orcid.org/0000-0003-0255-5467)
- Huanhuan Sun (ORCID: https://orcid.org/0000-0001-6946-2957)
- Yang Zhou (ORCID: https://orcid.org/0000-0002-7076-9056)
- Peipei Zhou (ORCID: https://orcid.org/0000-0001-9033-2559)
- Ting He
Institutions
- Sun Yat-sen University (CN)
- Zhuhai People's Hospital (CN)
- Fifth Affiliated Hospital of Sun Yat-sen University (CN)
- Guangdong Academy of Medical Sciences (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1016/j.tranon.2025.102404
- Primary Topic
- Estrogen and related hormone effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- High-level Hospital Construction Project of Guangdong Provincial People's Hospital